SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

VOLTAN, Rebecca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.768
EU - Europa 1.472
AS - Asia 881
SA - Sud America 5
OC - Oceania 4
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.132
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.754
IT - Italia 462
CN - Cina 386
PL - Polonia 246
SG - Singapore 245
UA - Ucraina 217
DE - Germania 199
TR - Turchia 126
GB - Regno Unito 111
SE - Svezia 59
ID - Indonesia 54
FI - Finlandia 53
VN - Vietnam 29
FR - Francia 24
NL - Olanda 23
CZ - Repubblica Ceca 15
RU - Federazione Russa 15
HK - Hong Kong 14
BE - Belgio 13
CA - Canada 12
IE - Irlanda 7
KR - Corea 7
IN - India 6
LT - Lituania 6
ES - Italia 5
AU - Australia 4
BR - Brasile 4
BG - Bulgaria 3
IR - Iran 3
JP - Giappone 3
RO - Romania 3
TW - Taiwan 3
AL - Albania 2
CH - Svizzera 2
MX - Messico 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BD - Bangladesh 1
CL - Cile 1
DK - Danimarca 1
GR - Grecia 1
IL - Israele 1
KE - Kenya 1
LU - Lussemburgo 1
MC - Monaco 1
MD - Moldavia 1
NO - Norvegia 1
PT - Portogallo 1
Totale 7.132
Salva come PNG Salva come JPEG
Città #
Fairfield 722
Woodbridge 603
Houston 390
Ashburn 324
Chandler 303
Seattle 280
Ann Arbor 279
Cambridge 268
Jacksonville 266
Wilmington 246
Warsaw 242
Ferrara 240
Singapore 177
Santa Clara 157
Izmir 87
Beijing 85
Boardman 72
Nanjing 68
Princeton 61
New York 58
Jakarta 54
San Diego 46
Shanghai 42
Milan 39
Dong Ket 29
Falls Church 27
Los Angeles 26
Bremen 24
Bologna 22
Nanchang 22
Shenyang 20
London 19
Hebei 18
Dearborn 16
Brno 15
Munich 15
Changsha 14
Brussels 13
Norwalk 13
Hong Kong 12
Kunming 12
Washington 12
Jiaxing 10
Mountain View 9
Orange 9
Tappahannock 9
Tianjin 9
Auburn Hills 8
Redwood City 8
Toronto 8
Imola 7
Rome 7
Taizhou 7
Chicago 6
Dronten 6
Frankfurt am Main 6
Guangzhou 6
Jinan 6
Naples 6
San Mateo 6
Augusta 5
Ferrara di Monte Baldo 5
Florence 5
Nam-gu 5
Ningbo 5
Catania 4
Des Moines 4
Forlì 4
Gdansk 4
Haikou 4
Helsinki 4
Rimini 4
Zhengzhou 4
Ardabil 3
Cattolica 3
Ottawa 3
Padova 3
Turin 3
Varna 3
Agropoli 2
Alicante 2
Amsterdam 2
Bari 2
Cagliari 2
Castel San Pietro Terme 2
Changchun 2
Cheongju-si 2
Chiswick 2
Cologno Monzese 2
Genoa 2
Hangzhou 2
Hefei 2
Lanzhou 2
Lappeenranta 2
Leawood 2
New Delhi 2
Parma 2
Redmond 2
Reggio Emilia 2
Rennes 2
Totale 5.688
Salva come PNG Salva come JPEG
Nome #
Intranasal Administration of Recombinant TRAIL Down-Regulates CXCL-1/KC in an Ovalbumin-Induced Airway Inflammation Murine Model 187
MDM2/X inhibitors under clinical evaluation: Perspectives for the management of hematological malignancies and pediatric cancer 172
Design, synthesis and biological characterization of novel mitochondria targeted dichloroacetate-loaded compounds with antileukemic activity 171
Expeditious Synthesis and Biological Characterization of Enantio-Enriched (-)-Nutlin-3 161
Metformin combined with sodium dichloroacetate promotes B leukemic cell death by suppressing anti-apoptotic protein Mcl-1 159
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 157
Serum From Advanced Heart Failure Patients Promotes Angiogenic Sprouting and Affects the Notch Pathway in Human Endothelial Cells 156
The p53 transcriptional pathway is preserved in ATMmutated and NOTCH1mutated chronic lymphocytic leukemias 148
HelixComplex snail mucus exhibits pro-survival, proliferative and pro-migration effects on mammalian fibroblasts 146
Multiple dye-doped NIR-emitting silica nanoparticles for both flow cytometry and in vivo imaging 145
Changes in expression profiles of internal jugular vein wall and plasma protein levels in multiple sclerosis 135
Proper design of silica nanoparticles combines high brightness, lack of cytotoxicity and efficient cell endocytosis 133
The Sorafenib plus Nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of the FLT3 and p53 status 129
Nanoparticles Loaded with Nutlin-3 Display Cytotoxicity Towards p53(wild-type) JVM-2 But Not Towards p53(mutated) BJAB Leukemic Cells 129
Clinical perspectives of TRAIL: Insights into central nervous system disorders 129
Relationship between low levels of circulating TRAIL and atheromatosis progression in patients with chronic kidney disease 129
Actively targeted nanocarriers for drug delivery to cancer cells 123
Redox signaling and oxidative stress: Cross talk with TNF-related apoptosis inducing ligand activity 121
The Tat protein broadens T cell responses directed to the HIV-1 antigens Gag and Env: Implications for the design of new vaccination strategies against AIDS 118
Anti-leukemic activity of Dasatinib in both p53(wild-type) and p53 (mutated) B malignant cells. 118
Coagulation Factor XII Levels and Intrinsic Thrombin Generation in Multiple Sclerosis 115
Enhanced cellular immunity to SIV Gag following co-administration of adenoviruses encoding wild-type or mutant HIV Tat and SIV Gag. 112
Cell cycle block by p53 activation reduces SARS-CoV-2 release in infected alveolar basal epithelial A549-hACE2 cells 105
Nutlin-3 differentially modulates miRNA34a and miRNA181 versus miR26a and miR155 in p53 proficient and p53 deficient B chronic lymphocytic leukemia (B-CLL) samples 105
Heterogeneity of mesenchymal stromal cells in lymphoproliferative disorders 105
Priming with a very low dose of DNA complexed with cationic block copolymers followed by protein boost elicits broad and long-lasting antigen-specific humoral and cellular responses in mice 104
Anticancer Activity of Aqueous Extracts from Asparagus officinalis L. Byproduct on Breast Cancer Cells 104
null 103
null 101
The oncogene DEK promotes leukemic cell survival and is downregulated by both nutlin-3 and chlorambucil in B-chronic lymphocytic leukemic cells 101
Live recombinant vectors for AIDS vaccine development 101
The gamma-secretase inhibitors enhance the anti-leukemic activity of ibrutinib in B-CLL cells 101
null 100
Rhesus macaque resistance to mucosal simian immunodeficiency virus infection is associated with a postentry block in viral replication 99
null 97
Applications of nanoparticles in cancer medicine and beyond: optical and multimodal in vivo imaging, tissue targeting and drug delivery 95
null 94
Perspectives of protein kinase C (PKC) inhibitors as anti-cancer agents 94
null 92
MCL1 down-regulation plays a critical role in mediating the higher anti-leukaemic activity of the multi-kinase inhibitor Sorafenib with respect to Dasatinib. 92
Replicating Ad-recombinants encoding non-myristoylated rather than wild-type HIV Nef elicit enhanced cellular immunity. 92
SRP-35, a newly identified protein of the skeletal muscle sarcoplasmic reticulum, is a retinol dehydrogenase 91
TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets? 91
null 90
null 90
null 89
p53 and merlin tumor suppressors: Two of a kind 89
null 88
Netter's Introduzione all'imaging 86
null 86
null 86
Preparation and characterization of innovative protein-coated poly(methylmethacrylate) core-shell nanoparticles for vaccine purposes. 85
null 84
null 83
null 81
null 74
Overcoming of Microenvironment Protection on Primary Chronic Lymphocytic Leukemia Cells after Treatment with BTK and MDM2 Pharmacological Inhibitors 60
Antitumoral activity of Asparagus officinalis extracts against breast cancer 59
null 55
Cell cycle block by p53 acrivation reduces SARS-COV-2 release in infected alveolar basal epithelial A549-hACE2 cells 49
null 43
null 42
DNA prime and protein boost immunization with innovative polymeric cationic core-shell nanoparticles elicits broad immune responses and strongly enhance cellular responses of HIV-1 tat DNA vaccination 40
The expression levels of the pro-apoptotic XAF-1 gene modulate the cytotoxic response to Nutlin-3 in B chronic lymphocytic leukemia 39
Use of bioactives from agrifood by-products in topical cosmetic hydrogels 38
Activation of PKC-epsilon counteracts maturation and apoptosis of HL-60 myeloid leukemic cells in response to TNF family members 34
Activation of the p53 pathway induces α-smooth muscle actin expression in both myeloid leukemic cells and normal macrophages 33
miR-34a induces the downregulation of both E2F1 and B-Myb oncogenes in leukemic cells. 30
In vitro endothelial cell proliferation assay reveals distinct levels of proangiogenic cytokines characterizing sera of healthy subjects and of patients with heart failure 30
Ethosomes nanodelivery of the MDM2 inhibitor Nutlin-3a efficiently induces cells death in melanoma 29
Dasatinib plus Nutlin-3 shows synergistic anti-leukemic activity in both p53wild-type and p53mutated B chronic lymphocytic leukemias by inhibiting the Akt pathway. 29
Characterization of immune responses elicited in mice by intranasal co-immunization with HIV-1 Tat, gp140 DeltaV2Env and/or SIV Gag proteins and the nontoxicogenic heat-labile Escherichia coli enterotoxin 28
Human Full-Length Osteoprotegerin Induces the Proliferation of Rodent Vascular Smooth Muscle Cells both in vitro and in vivo 26
Endothelial cells obtained from patients affected by chronic venous disease exhibit a pro-inflammatory phenotype. 26
Perifosine plus nutlin-3 combination shows a synergistic anti-leukaemic activity. 25
Characterization of HIV-1 Tat proteins mutated in the transactivation domain for prophylactic and therapeutic application 23
Nutrients, herbal bioactive derivatives and commensal microbiota as tools to lower the risk of SARS-CoV-2 infection 22
Asparagus officinalis L. aqueous extracts mediate cell cycle block and migration inhibition in breast cancer cells 21
Characterization Methods for Nanoparticle–Skin Interactions: An Overview 20
Nutlin-3 downregulates the expression of the Oncogene TCL1 in primary B Chronic Lymphocytic Leukemic cells. 20
MDM2 inhibitors counteract inflammation by stabilization of ACE2 in vitro 18
Oscillatory turbulent flow in chronic venous disease induces pro-inflammatory and reparative biological signaling 18
MDM2 inhibitors-mediated disruption of mitochondrial metabolism: A novel therapeutic strategy for retinoblastoma 17
Selective induction of TP53I3/p53-inducible gene 3 (PIG3) in myeloid leukemic cells, but not in normal cells, by Nutlin-3 17
State of the art of the therapeutic perspective of sorafenib against hematological malignancies 17
Cell cycle block by p53 activation reduces SARS-CoV-2 release in A549-hAce2 cells 16
Nanoparticles engineered with Rituximab and loaded with Nutlin-3 show promising therapeutic activity in B leukemic xenografts 16
null 15
Induction of humoral and enhanced cellular immune responses by novel core-shell nanosphere- and microsphere-based vaccine formulations following systemic and mucosal administration 15
Nutlin-3a-loaded ethosomes as a delivery system in vitro to Target p53 in melanoma 13
Nutlin-3 Loaded Ethosomes and Transethosomes to Prevent UV-Associated Skin Damage 12
MDM2 non-genotoxic inhibitors as innovative therapeutic approaches for the treatment of pediatric malignancies 12
Perifosine selectively induces cell cycle block and modulates retinoblastoma and E2F1 protein levels in p53 mutated leukemic cell lines. 12
Therapeutic potential of the MDM2 inhibitor Nutlin-3 in counteracting SARS-CoV-2 infection of the eye through p53 activation 11
Enhanced Anti-Melanoma Activity of Nutlin-3a Delivered via Ethosomes: Targeting p53-Mediated Apoptosis in HT144 Cells 8
ACE2 up-regulation by MDM2 inhibition reduces inflammation and monocytes adhesion in HUVEC 6
In-vitro anticancer activity of Asparagus officinalis extracts on breast carcinoma 3
Effects of Nutlin-3a on endothelial cells in the presence of inflammation 3
Totale 7.321
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.403
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.403
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020971 0 0 0 0 114 166 155 167 139 134 59 37
2020/20211.304 64 105 39 105 117 139 93 136 58 238 131 79
2021/2022719 25 75 57 37 89 45 44 28 31 54 71 163
2022/2023767 66 48 32 91 108 98 35 66 99 32 56 36
2023/2024544 57 43 20 15 29 74 21 58 17 16 42 152
2024/2025687 62 75 174 121 255 0 0 0 0 0 0 0
Totale 7.321